Diets for Multiple Sclerosis
(Waves Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how two different diets might impact fatigue in people with relapsing-remitting multiple sclerosis. Participants will first follow their usual diet, then try either the Swank Diet, low in saturated fats, or the Wahls Elimination Diet, a modified paleo diet. This trial suits individuals with multiple sclerosis who experience fatigue and are open to significantly changing their eating habits. Participants must be able to walk short distances and prepare meals. As an unphased trial, this study provides a unique opportunity for participants to explore dietary changes that could enhance their quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking insulin or Coumadin.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both the Swank and Wahls Elimination diets are generally safe for people with multiple sclerosis. One study found that these diets can reduce tiredness and improve quality of life for up to 24 weeks, indicating they are well-tolerated by most individuals.
The Swank Diet is low in saturated fats, and reviews suggest it can help with tiredness and overall well-being in people with multiple sclerosis. No strong evidence indicates major safety concerns.
The Wahls Elimination Diet is a modified paleo diet that excludes grains, dairy, eggs, legumes, and some vegetables. While it can enhance mental quality of life, caution is advised as eliminating these foods might lead to nutrient deficiencies.
Overall, both diets appear safe for most individuals, but consulting a healthcare provider before making significant dietary changes is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about these dietary treatments for multiple sclerosis (MS) because they offer a unique, non-pharmaceutical approach that could complement or even reduce the need for standard medications like disease-modifying therapies. The Swank Diet is distinctive for its focus on drastically reducing saturated fat intake, which may help reduce inflammation and slow disease progression. The Wahls Elimination Diet stands out by eliminating grains, dairy, eggs, legumes, and nightshade vegetables, aiming to optimize nutrient intake and reduce autoimmunity triggers. These diets are intriguing because they empower individuals with MS to potentially manage symptoms through lifestyle changes rather than solely relying on medication.
What evidence suggests that this trial's diets could be effective for reducing fatigue in multiple sclerosis?
In this trial, participants will be randomized to follow either the Swank Diet or the Wahls Elimination Diet. Research has shown that both diets can reduce tiredness and improve the quality of life for people with multiple sclerosis (MS). One study found that following these diets for up to 24 weeks led to these positive effects. Participants in one arm of this trial will follow the Swank Diet, which is low in saturated fat and may slow the progression of MS. Meanwhile, participants in another arm will follow the Wahls Elimination Diet, a modified paleo diet that improves tiredness and quality of life by focusing on nutrient-rich foods. To achieve these benefits, adherence to the assigned diet is crucial.14678
Who Is on the Research Team?
Linda Snetselaar, PhD, RD,
Principal Investigator
University of Iowa
Terry L Wahls, MD, MBA
Principal Investigator
University of Iowa
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 with relapsing-remitting multiple sclerosis and fatigue, willing to eat meat and more vegetables while cutting out comfort foods. Participants must not be pregnant or planning pregnancy, able to walk with minimal support, and capable of preparing meals according to diet guidelines.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Diet
Participants follow their usual diet for 12 weeks
Dietary Intervention
Participants are randomly assigned to follow either the Swank Diet or the Wahls Elimination Diet for 24 weeks
Follow-up
Participants are monitored for changes in fatigue, motor function, cognitive function, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Swank Diet
- Wahls Elimination Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Terry L. Wahls
Lead Sponsor
National Multiple Sclerosis Society
Collaborator